ABCC6 Prevents Ectopic Mineralization Seen in Pseudoxanthoma Elasticum by Inducing Cellular Nucleotide Release

Total Page:16

File Type:pdf, Size:1020Kb

ABCC6 Prevents Ectopic Mineralization Seen in Pseudoxanthoma Elasticum by Inducing Cellular Nucleotide Release ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release Robert S. Jansena, Aslı Küçükosmanoglu a, Marcel de Haasb, Sunny Sapthua, Jon Andoni Oteroc, Ilse E. M. Hegmana, Arthur A. B. Bergend,e,f, Theo G. M. F. Gorgelsd, P. Borsta,1, and Koen van de Weteringa,1 Divisions of aMolecular Oncology and bGene Regulation, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; cDepartment of Biomedical Sciences-Physiology, University of Leon, 24071 Leon, Spain; dDepartment of Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience (NIN-KNAW), 1105 BA, Amsterdam, The Netherlands; and Departments of eClinical Genetics and fOphthalmology, Academic Medical Center, 1105 AZ, Amsterdam, The Netherlands Contributed by P. Borst, October 21, 2013 (sent for review July 2, 2013) − − Pseudoxanthoma elasticum (PXE) is an autosomal recessive dis- a metabolic disease (13–16). Abcc6 / muzzle skin that miner- − − ease characterized by progressive ectopic mineralization of the alizes in Abcc6 / mice does not mineralize when grafted onto skin, eyes, and arteries, for which no effective treatment exists. WT mice, and muzzle skin of WT mice mineralizes only when − − PXE is caused by inactivating mutations in the gene encoding ATP- grafted onto Abcc6 / mice (17). Moreover, surgically joining the − − binding cassette sub-family C member 6 (ABCC6), an ATP-dependent systemic circulation of Abcc6 / mice with that of WT mice halts fl Abcc6−/− − − ef ux transporter present mainly in the liver. mice have mineralization in Abcc6 / mice (18). Thus, PXE is caused not by been instrumental in demonstrating that PXE is a metabolic dis- a lack of functional ABCC6 in the affected tissues, but rather by ease caused by the absence of an unknown factor in the circula- the absence of a factor that is normally provided to the circu- tion, the presence of which depends on ABCC6 in the liver. Why lation by an ABCC6-dependent mechanism. The nature of this absence of this factor results in PXE has remained a mystery. Here factor has remained elusive. we report that medium from HEK293 cells overexpressing either In vitro vesicular uptake experiments have confirmed that human or rat ABCC6 potently inhibits mineralization in vitro, fl MEDICAL SCIENCES whereas medium from HEK293 control cells does not. Untargeted ABCC6, like its close homolog ABCC1, is an ef ux transporter, metabolomics revealed that cells expressing ABCC6 excrete large transporting a handful of glutathione-conjugates and the cyclic fi amounts of nucleoside triphosphates, even though ABCC6 itself peptide BQ-123 (10, 19, 20). The short list of identi ed ABCC6 does not transport nucleoside triphosphates. Extracellularly, ecto- substrates does not include any compound obviously relevant for nucleotidases hydrolyze the excreted nucleoside triphosphates to PXE, and the only substrate shared by human ABCC6 (hABCC6) nucleoside monophosphates and inorganic pyrophosphate (PPi), and rat ABCC6 (rABCC6) is not an endogenous compound, but a strong inhibitor of mineralization that plays a pivotal role in rather the synthetic cyclic peptide BQ-123. Based on the clinical several mineralization disorders similar to PXE. The in vivo rele- similarities of PXE to other diseases, vitamin K conjugates (21) vance of our data are demonstrated in Abcc6−/− mice, which had and adenosine (22) have been proposed as substrates, but none of plasma PPi levels <40% of those found in WT mice. This study these are actually transported (23, 24). provides insight into how ABCC6 affects PXE. Our data indicate Thus, despite all efforts, the mechanism by which ABCC6 that the factor that normally prevents PXE is PPi, which is provided prevents ectopic mineralization remains a mystery, and no at- to the circulation in the form of nucleoside triphosphates via an as- tractive new hypotheses about the nature of the physiological fi yet unidenti ed but ABCC6-dependent mechanism. ABCC6 substrate have been proposed. In the present study, we used untargeted metabolomics to screen for ABCC6-dependent ATP secretion | ectopic calcification | MRP6 | ENPP1 Significance seudoxanthoma elasticum (PXE) is an autosomal recessive Pdisease characterized by late-onset and progressive ectopic Pseudoxanthoma elasticum (PXE) is a heritable disease char- mineralization of skin, eyes, and arteries (1). This prototypical ∼ acterized by mineralization of the skin, eyes, and arteries, for connective tissue disease affects 1 in 50,000 persons worldwide, which no effective treatment exists. PXE is caused by inacti- for whom there is no effective therapy (2). Along with relatively vating mutations in the gene encoding the transporter ABCC6. benign (but stigmatizing) skin lesions, PXE causes progressive loss PXE is a metabolic disease caused by the absence of an un- of vision and cardiovascular complications (2). The severity of these known factor in the circulation. Our study indicates that the symptoms is highlyvariable among patients, even within families (3). factor that normally prevents PXE is pyrophosphate, which is In 2000, multiple research groups reported that PXE is caused provided to the circulation in the form of nucleoside triphos- by inactivating mutations in the ATP-binding cassette sub-family phates via an ABCC6-dependent mechanism. Our findings C member 6 (ABCC6) gene (4–7). ABCC6, also known as mul- provide leads for the treatment of this intractable disease. tidrug resistance-associated protein 6 (MRP6), is a member of the C branch of the superfamily of ATP-binding cassette (ABC)- Author contributions: P.B. and K.v.d.W. designed research; R.S.J., A.K., M.d.H., S.S., J.A.O., transporters, which use the energy provided by the hydrolysis of I.E.M.H., T.G.M.F.G., and K.v.d.W. performed research; A.A.B.B. contributed new reagents/ ATP to transport substrates across a membrane (8). ABCC6 analytic tools; R.S.J. analyzed data; and R.S.J., P.B., and K.v.d.W. wrote the paper. expression is high in the liver, lower in the kidney, and very low The authors declare no conflict of interest. or absent in other tissues, including affected skin, eyes, and Data deposition: Untargeted metabolomics data are available through MetaboLights, www.ebi.ac.uk/metabolights (accession no. MTBLS61) and XCMS Online, https:// arteries (5, 9). In the liver, ABCC6 is present in the sinusoidal xcmsonline.scripps.edu/jobs.php?action=listpublicshares (ID 1009444–1009446). (basolateral) membrane of hepatocytes, facing the central cir- 1To whom correspondence may be addressed. E-mail: [email protected] or k.vd.wetering@ culation (10–12). nki.nl. −/− Abcc6 mice faithfully recapitulate most of the symptoms of This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. PXE and have been indispensable for showing that PXE is 1073/pnas.1319582110/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1319582110 PNAS Early Edition | 1of6 Downloaded by guest on September 26, 2021 factors that inhibit mineralization, to shed more light on the basic ribonucleosides, which could explain why they were not mechanism by which ABCC6 prevents pathological mineralization. detected. Even though nucleosides, nucleotides, and nucleotide sugars account for the major differences, we also found differ- Results ences (both increases and decreases) in the levels of compounds ABCC6-Conditioned Medium Inhibits Mineralization in Vitro. PXE is that we could not identify. All raw data are available at the a metabolic disease caused by the absence of a factor, the MetaboLights repository, and the processed data are accessible presence of which depends on ABCC6 in the liver (17). Jiang on XCMS Online (25, 26). and coworkers (14, 18) previously showed that in an in vitro + + system using vascular smooth muscle cells, serum from Abcc6 / ABCC6 Increases Extracellular Pyrophosphate Levels. None of the mice inhibits mineralization to a greater extent than serum from compounds found to be increased in medium of ABCC6-con- − − Abcc6 / mice. We took a similar approach to test whether a taining cells could be linked directly to mineralization. A differ- mineralization-inhibiting factor is also present in medium from entially present compound with an exceptionally high abundance HEK293 cells overexpressing human ABCC6 (HEK293/hABCC6) and fold change in medium of ABCC6-containing cells was or rat ABCC6 (HEK293/rABCC6). Both HEK293/hABCC6- and adenosine monophosphate (AMP). Although AMP itself is not HEK293/rABCC6-conditioned medium potently inhibited miner- known to affect mineralization, adenosine triphosphate (ATP) alization of ATDC5 cells, whereas medium from control cells does have a role in the prevention of ectopic mineralization. ATP (HEK293/GFP) did not (Fig. 1). These results indicate that the can be hydrolyzed to AMP and the mineralization inhibitor in- factor that prevents mineralization in vivo is also extruded from organic pyrophosphate (PPi) by ectonucleotide pyrophosphatase- cultured HEK293 cells containing ABCC6 in vitro. phosphodiesterase (ENPP)-type ectonucleotidases (27). PPi was not detected by our untargeted metabolomics method, however, ABCC6-Conditioned Medium Contains High Levels of Nucleosides and owing to the chosen mass range. Thus, we tested whether PPi Nucleotides. To identify the ABCC6-dependent factor responsible levels were affected by the presence of ABCC6 using a specific for inhibition of mineralization, we generated global metabolite enzymatic assay. The PPi levels in HEK293/hABCC6 and profiles of plasma samples as well
Recommended publications
  • ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Yu Fukuda University of Tennessee Health Science Center
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2008 ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Yu Fukuda University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Chemicals and Drugs Commons, and the Medical Sciences Commons Recommended Citation Fukuda, Yu , "ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters" (2008). Theses and Dissertations (ETD). Paper 345. http://dx.doi.org/10.21007/etd.cghs.2008.0100. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Interdisciplinary Program Research Advisor John D. Schuetz, Ph.D. Committee Linda Hendershot, Ph.D. James I. Morgan, Ph.D. Anjaparavanda P. Naren, Ph.D. Jie Zheng, Ph.D. DOI 10.21007/etd.cghs.2008.0100 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/345 ABCB6 IS A PORPHYRIN TRANSPORTER WITH A NOVEL TRAFFICKING SIGNAL THAT
    [Show full text]
  • Updates on Mutations in ATP Binding Cassette Proteins
    Database, 2017, 1–11 doi: 10.1093/database/bax023 Original article Original article ABCMdb reloaded: updates on mutations in ATP binding cassette proteins Hedvig Tordai,1,† Kristof Jakab,1,† Gergely Gyimesi,2 Kinga Andras, 1 Anna Brozik, 3 Balazs Sarkadi3 and Tamas Hegedus} 1,* 1MTA-SE Molecular Biophysics Research Group, Hungarian Academy of Sciences and Department of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary, 2Institute of Biochemistry and Molecular Medicine, University of Bern, Bern 3012, Switzerland and 3Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest 1117, Hungary *Corresponding author: phone: þ36 1-459-1500/60233; fax: þ36 1-266-6656; Email: [email protected] †These authors contributed equally to this work. Citation details: Tordai,H., Jakab,K., Gyimesi,G. et al. ABCMdb reloaded: updates on mutations in ATP binding cassette proteins. Database (2017) Vol. 2017: article ID bax023; doi:10.1093/database/bax023 Received 22 December 2016; Revised 5 February 2017; Accepted 23 February 2017 Abstract ABC (ATP-Binding Cassette) proteins with altered function are responsible for numerous human diseases. To aid the selection of positions and amino acids for ABC structure/ function studies we have generated a database, ABCMdb (Gyimesi et al., ABCMdb: a database for the comparative analysis of protein mutations in ABC transporters, and a potential framework for a general application. Hum Mutat 2012; 33:1547–1556.), with interactive tools. The database has been populated with mentions of mutations extracted from full text papers, alignments and structural models. In the new version of the data- base we aimed to collect the effect of mutations from databases including ClinVar.
    [Show full text]
  • Whole-Exome Sequencing Identifies Novel Mutations in ABC Transporter
    Liu et al. BMC Pregnancy and Childbirth (2021) 21:110 https://doi.org/10.1186/s12884-021-03595-x RESEARCH ARTICLE Open Access Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study Xianxian Liu1,2†, Hua Lai1,3†, Siming Xin1,3, Zengming Li1, Xiaoming Zeng1,3, Liju Nie1,3, Zhengyi Liang1,3, Meiling Wu1,3, Jiusheng Zheng1,3* and Yang Zou1,2* Abstract Background: Intrahepatic cholestasis of pregnancy (ICP) can cause premature delivery and stillbirth. Previous studies have reported that mutations in ABC transporter genes strongly influence the transport of bile salts. However, to date, their effects are still largely elusive. Methods: A whole-exome sequencing (WES) approach was used to detect novel variants. Rare novel exonic variants (minor allele frequencies: MAF < 1%) were analyzed. Three web-available tools, namely, SIFT, Mutation Taster and FATHMM, were used to predict protein damage. Protein structure modeling and comparisons between reference and modified protein structures were performed by SWISS-MODEL and Chimera 1.14rc, respectively. Results: We detected a total of 2953 mutations in 44 ABC family transporter genes. When the MAF of loci was controlled in all databases at less than 0.01, 320 mutations were reserved for further analysis. Among these mutations, 42 were novel. We classified these loci into four groups (the damaging, probably damaging, possibly damaging, and neutral groups) according to the prediction results, of which 7 novel possible pathogenic mutations were identified that were located in known functional genes, including ABCB4 (Trp708Ter, Gly527Glu and Lys386Glu), ABCB11 (Gln1194Ter, Gln605Pro and Leu589Met) and ABCC2 (Ser1342Tyr), in the damaging group.
    [Show full text]
  • Expression Profiling of ATP-Binding Cassette Transporters in Childhood T-Cell Acute Lymphoblastic Leukemia
    1986 Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia Thomas Efferth,1 Jean-Pierre Gillet,2 of both transporters. As a consequence, a significant Axel Sauerbrey,3 Felix Zintl,4 Vincent Bertholet,5 sensitization of cells to cytostatic drugs was achieved. In Franc¸oise de Longueville,5 Jose Remacle,6 conclusion, ABCA2 and ABCA3 are expressed in many and Daniel Steinbach4 T-ALL and contribute to drug resistance. [Mol Cancer Ther 2006;5(8):1986–94] 1German Cancer Research Center, Heidelberg, Germany; 2Laboratory of Cell Biology, National Cancer Institute, NIH, Introduction Bethesda, Maryland; 3Helios Children’s Hospital, Erfurt, Germany; 4Children’s Hospital, University of Jena, Jena, Germany; Although cancer therapy for childhood T cell acute 5Department of Biology, University of Namur; and 6Eppendorf lymphoblastic leukemia (T-ALL) has remarkably improved Array Technologies, Namur, Belgium during the past two decades, and normal life expectancy is a reality for many patients, a considerable number Abstract of patients cannot permanently be cured. In the majority of children suffering from T-ALL, remissions can be achieved A major issue in the treatment of T-cell acute lympho- by chemotherapy. Nevertheless, f25% of the patients blastic leukemia (T-ALL) is resistance to chemotherapeutic develop relapses. One major reason is the development drugs. Multidrug resistance can be caused by ATP-binding of drug resistance. In patients with a T cell immunophe- cassette (ABC) transporters. The majority of these notype (T-ALL), drug resistance is even more commonly proteins have not yet been examined in T-ALL. Using a encountered. newly developed microarray for the simultaneous quanti- The expression of one drug resistance gene, the multi- fication of 38 ABC transporter genes, we observed a drug resistance gene, MDR1,anditsgeneproduct, ABCA2/ABCA3 consistent overexpression of in clinical P-glycoprotein, has been well documented in leukemia.
    [Show full text]
  • Mutation Spectrum in the ABCC6 Gene and Genotype&Ndash
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE Mutation spectrum in the ABCC6 gene and genotype–phenotype correlations in a French cohort with pseudoxanthoma elasticum Anne Legrand, PharmD1,2,3, Laurence Cornez, PhD4, Wafa Samkari, MD1, Jean-Michael Mazzella1, Annabelle Venisse1, Valérie Boccio1, Karine Auribault, PhD1, Boris Keren, MD, PhD5, Karelle Benistan, MD6, Dominique P. Germain, MD, PhD6,7,8, Michael Frank, MD1,2, Xavier Jeunemaitre, MD, PhD1,2,3 and Juliette Albuisson, MD, PhD1,2,3 Purpose: Pseudoxanthoma elasticum (PXE) is an autosomal reces- distinct variants, of which 66 were novel. Missense variant distribu- sive disorder caused by variants in the ABCC6 gene. Ectopic miner- tion was specific to some regions and residues of ABCC6. For the 220 alization of connective tissues leads to skin, eye, and cardiovascular cases with a complete PS, there was a higher prevalence of eye fea- manifestations with considerable phenotypic variability of unknown tures in Caucasian patients (P = 0.03) and more severe eye and vas- cause. We aimed to identify genotype–phenotype correlations in cular phenotype in patients with loss-of-function variants (P = 0.02 PXE. and 0.05, respectively). Nephrolithiases and strokes, absent from the PS, were prevalent features of the disorder (11 and 10%, respectively). Methods: A molecular analysis was performed on 458 French PXE probands clinically evaluated using the Phenodex score (PS). Variant Conclusion: We propose an updated PS including renal and neuro- topographic analysis and genotype–phenotype correlation analysis logical features and adaptation of follow-up according to the genetic were performed according to the number and type of identified vari- and ethnic status of PXE-affected patients.
    [Show full text]
  • Identification of a New Splice Variant of the Human ABCC6 Transporter
    Hindawi Publishing Corporation Research Letters in Biochemistry Volume 2008, Article ID 912478, 4 pages doi:10.1155/2008/912478 Research Letter Identification of a New Splice Variant of the Human ABCC6 Transporter Maria Francesca Armentano,1 Angela Ostuni,1 Vittoria Infantino,2 Vito Iacobazzi,2 Maria Antonietta Castiglione Morelli,1 and Faustino Bisaccia1 1 Department of Chemistry, University of Basilicata, 85100 Potenza, Italy 2 Department of Pharmaco Biology, University of Bari, 75100 Bari, Italy Correspondence should be addressed to Faustino Bisaccia, [email protected] Received 11 August 2008; Accepted 28 September 2008 Recommended by Anita H. Corbett ABCC6 is a member of the adenosine triphosphate-binding cassette (ABC) gene subfamily C that encodes a protein (MRP6) involved in active transport of intracellular compounds to the extracellular environment. Mutations in ABCC6 cause pseudoxanthoma elasticum (PXE), an autosomal recessive disorder of the connective tissue characterized by progressive calcification of elastic structures in the skin, the eyes, and the cardiovascular system. MRP6 is codified by 31 exons and contains 1503 amino acids. In addition to a full-length transcript of ABCC6, we have identified an alternatively spliced variant of ABCC6 from a cDNA of human liver that lacks exons 19 and 24. The novel isoform was named ABCC6 Δ19Δ24. PCR analysis from cDNA of cell cultures of primary human hepatocites and embryonic kidney confirms the presence of the ABCC6Δ19Δ24 isoform. Western blot analysis of the embryonic kidney cells shows a band corresponding to the molecular weight of the truncated protein. Copyright © 2008 Maria Francesca Armentano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Categorization and Classification of Different ABCA3 Variants Causing Interstitial Lung Disease
    Categorization and classification of different ABCA3 variants causing interstitial lung disease Dissertation der Mathematisch-Naturwissenschaftlichen Fakultät der Eberhard Karls Universität Tübingen zur Erlangung des Doktorgrades Doktor der Naturwissenschaften (Dr. rer. nat.) vorgelegt von Thomas Wittmann aus Neumarkt in der Oberpfalz, Deutschland Tübingen 2016 Gedruckt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Eberhard Karls Universität Tübingen. Tag der mündlichen Qualifikation: 15.07.2016 Dekan: Prof. Dr. Wolfgang Rosenstiel 1. Berichterstatter: Prof. Dr. Dominik Hartl 2. Berichterstatter: Prof. Dr. Andreas Peschel Table of contents Table of contents Table of contents ..........................................................................................................I List of tables.................................................................................................................II List of figures................................................................................................................II Abbreviations ..............................................................................................................III Summary..................................................................................................................... V Zusammenfassung .................................................................................................... VI Publications.............................................................................................................
    [Show full text]
  • Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response
    International Journal of Molecular Sciences Article Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response Viktor Hlaváˇc 1,2 , Radka Václavíková 1,2, Veronika Brynychová 1,2, Renata Koževnikovová 3, Katerina Kopeˇcková 4, David Vrána 5 , Jiˇrí Gatˇek 6 and Pavel Souˇcek 1,2,* 1 Toxicogenomics Unit, National Institute of Public Health, 100 42 Prague, Czech Republic; [email protected] (V.H.); [email protected] (R.V.); [email protected] (V.B.) 2 Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic 3 Department of Oncosurgery, Medicon Services, 140 00 Prague, Czech Republic; [email protected] 4 Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic; [email protected] 5 Department of Oncology, Medical School and Teaching Hospital, Palacky University, 779 00 Olomouc, Czech Republic; [email protected] 6 Department of Surgery, EUC Hospital and University of Tomas Bata in Zlin, 760 01 Zlin, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-267-082-711 Received: 19 November 2020; Accepted: 11 December 2020; Published: 15 December 2020 Abstract: Breast cancer is the most common cancer in women in the world. The role of germline genetic variability in ATP-binding cassette (ABC) transporters in cancer chemoresistance and prognosis still needs to be elucidated. We used next-generation sequencing to assess associations of germline variants in coding and regulatory sequences of all human ABC genes with response of the patients to the neoadjuvant cytotoxic chemotherapy and disease-free survival (n = 105).
    [Show full text]
  • Final Dissertation V5
    UCLA UCLA Electronic Theses and Dissertations Title Heart Failure Genetics in Mice and Men Permalink https://escholarship.org/uc/item/4c59k544 Author Wang, Jessica Jen-Chu Publication Date 2014 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA Los Angeles Heart Failure Genetics in Mice and Men A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Human Genetics by Jessica Jen-Chu Wang 2014 ABSTRACT OF THE DISSERTATION Heart Failure Genetics in Mice and Men by Jessica Jen-Chu Wang Doctor of Philosophy in Human Genetics University of California, Los Angeles, 2014 Professor Aldons Jake Lusis, Chair The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of large effects predominate in theory, genetic testing using a gene panel of up to 76 genes returned negative results in about half of the cases. In common forms of heart failure (HF), where a large number of genes with small to modest effects are expected to modify disease, only a few candidate genomic loci have been identified through genome-wide association (GWA) analyses in humans. We aimed to use exome sequencing to rapidly identify rare causal mutations in familial cardiomyopathy cases and effectively filter and classify the variants based on family pedigree and family member samples. We identified a number of existing variants and novel genes with great potential to be disease causing. On the other hand, we also set out to understand genetic factors that predispose to common late-onset forms of heart failure by performing GWA in the isoproterenol-induced HF model across the Hybrid Mouse Diversity Panel (HMDP) of 105 strains of mice.
    [Show full text]
  • ABCC6 Gene ATP Binding Cassette Subfamily C Member 6
    ABCC6 gene ATP binding cassette subfamily C member 6 Normal Function The ABCC6 gene provides instructions for making a protein called multidrug resistance- associated protein 6 (MRP6, also known as the ABCC6 protein). This protein is found primarily in the liver and kidneys, with small amounts in other tissues such as the skin, stomach, blood vessels, and eyes. The MRP6 protein belongs to a group of proteins that transport molecules across cell membranes; however, little is known about the substances transported by MRP6. Some studies suggest that MRP6 stimulates the release of a molecule called adenosine triphosphate (ATP) from cells through an unknown mechanism. This ATP is quickly broken down into other molecules called adenosine monophosphate (AMP) and pyrophosphate. Pyrophosphate helps control deposition of calcium (calcification) and other minerals (mineralization) in the body. Other studies suggest that MRP6 transports a substance that is involved in the breakdown of ATP. This unidentified substance is thought to help prevent mineralization of tissues. Health Conditions Related to Genetic Changes Generalized arterial calcification of infancy At least 13 mutations in the ABCC6 gene have been identified in individuals with generalized arterial calcification of infancy (GACI), a life-threatening disorder characterized by abnormal calcification in the blood vessels that carry blood from the heart to the rest of the body (the arteries). Most of these mutations have also been identified in people with pseudoxanthoma elasticum (PXE), described below. These mutations lead to an absent or nonfunctional MRP6 protein. It is unclear how a lack of properly functioning MRP6 protein leads to GACI. This shortage may impair the release of ATP from cells.
    [Show full text]
  • Novel Deletions Causing Pseudoxanthoma Elasticum Underscore the Genomic Instability of the ABCC6 Region
    Journal of Human Genetics (2010) 55, 112–117 & 2010 The Japan Society of Human Genetics All rights reserved 1434-5161/10 $32.00 www.nature.com/jhg ORIGINAL ARTICLE Novel deletions causing pseudoxanthoma elasticum underscore the genomic instability of the ABCC6 region Laura MF Costrop1, Olivier OM Vanakker1, Lut Van Laer1, Olivier Le Saux1,2, Ludovic Martin3, Nicolas Chassaing4,5, Deanna Guerra6, Ivonne Pasquali-Ronchetti6, Paul J Coucke1 and Anne De Paepe1 Mutations in ABCC6 cause pseudoxanthoma elasticum (PXE), a heritable disease that affects elastic fibers. Thus far, 4200 mutations have been characterized by various PCR-based techniques (primarily direct sequencing), identifying up to 90% of PXE-causing alleles. This study wanted to assess the importance of deletions and insertions in the ABCC6 genomic region, which is known to have a high recombinational potential. To detect ABCC6 deletions/insertions, which can be missed by direct sequencing, multiplex ligation-dependent probe amplification (MLPA) was applied in PXE patients with an incomplete genotype. MLPA was performed in 35 PXE patients with at least one unidentified mutant allele after exonic sequencing and exclusion of the recurrent exon 23–29 deletion. Six multi-exon deletions and four single-exon deletions were detected. Using MLPA in addition to sequencing, we expanded the ABCC6 mutation spectrum with 9 novel deletions and characterized 25% of unidentified disease alleles. Our results further illustrate the instability of the ABCC6 genomic region and stress the importance of
    [Show full text]
  • Pseudoxanthoma Elasticum
    Analysis of ABCC6: Elucidation of the Molecular Pathology of Pseudoxanthoma Elasticum Xiaofeng Hu Acknowledgments The work for tbis thesis was conducted at the Department of Ophthalmogenetics of the Netherlands Ophthalmic Research Institute of the Royal Netherlands Academy of Arts and Science, Amsterdam, The Netherlands. This study was supported by a grant from the National Society for the Prevention ofBlindness (ANVtVvB). Financial support by Stichting voor Ooglijders, Alcon Netherland BV, and Visio for the printing of this thesis is gratefully acknowledged. Cover design: Zhang Lian Printed by: Print Partners Ipskamp, The Netherlands ISBN 9057761130 © Xiaofeng Hu, Amsterdam, 2003 Analysis of ABCC6: Elucidation of the Molecular Pathology of Pseudoxanthoma Elasticum ABCC6 Analyse: Opheldering van de Moleculaire Pathologie van Pseudoxanthoma Elasticum Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de Rector Magnificus Prof.dr.ir. J.H. van Bemmel en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op Woensdag 19 November 2003 om 11:45 uur door Xiaofeng Hu Geboren te Hubei, Volksrepubliek China Promotiecommissie Promotor: Prof. dr. P.T.V.M. de Jong Copromotor: Dr. A.A.B. Bergen Overige leden: Prof. dr. B.A. Oostra Prof. dr. ir. C.M. van Duijn Prof. dr. M.P. Niermeijer For my mother, and in the memory of my father To Baoxian and Jiyao Contents Chapter 1 1.1 Introduction 1 1.2 Pseudoxanthoma Elasticum(PXE): A clinical, histopathological and molecular update 7 Chapter 2 ABCC6/MRP6 mutations: Further insight into the molecular pathology of PXE 25 Chapter 3 Analysis of the frequent R1141X mutation in the ABCC6 gene in PXE 37 Chapter 4 Efficient Molecular Diagnostic Strategy for ABCC6 in PXE 45 Chapter 5 Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease.
    [Show full text]